Commercial in confidence 27 February 2025 Preliminary Full Year 2024 Results, Appendix 4E and Business Update Doctor Care Anywhere Group PLC (ASX:DOC, “Doctor Care Anywhere” or “the Company”) is pleased to provide its Preliminary Full Year results announcement and Appendix 4E for the year ended 31 December 2024. A business update is also provided.1 FY24 Highlights (vs FY23) • • • • • • All market guidance for 2024 was met or exceeded. Revenue growth of 8.9% versus 2023 (excluding secondary care pathway revenue) 58.1% GM, a 12.1ppt improvement versus 2023, as impact of ramp up of mixed clinical workforce and increase in 15-minute appointments seen throughout the business £5.4m improvement in underlying EBITDA loss - £ (0.5m) in 2024 New client wins in the year including MediChecks, Alliance Health, Taylor Wimpey and Orbital Strengthening of leadership team with the appointent of a new CEO and Product Development Director Laura O’Riordan, Chief Executive Officer of Doctor Care Anywhere, said: “Doctor Care Anywhere has made significant progress in 2024, delivering on our commitments and continuing to provide a high quality service to our clients. We have grown revenue and gross margin and continued to enhance our operating model. As we move forward, I am excited about the many opportunities we have to drive further growth and operational efficiencies as DCA builds on it’s leadership in UK primary care. Operational Performance Activated Lives reached 1,181,800 at 31 December 2024, representing a net increase of 133,400 (8.0%) above 31 December 2023. There remains considerable growth potential in activated lives given the Company’s existing base of 3.3 million Eligible Lives, plus further growth in patients from new clients as we broaden our client base and build on the multiple new client wins of 2024. Consultation volumes reduced by 2.7% in FY24, totalling 710,900. The reduction was primarily due to the phased closure of the Company’s secondary care pathway. Excluding these consultations, consultation reduction was under 1%. 1 This report is prepared in GBP in accordance with UK-adopted international accounting standards and in conformity with the requirements of the Companies Act 2006 (UK). All figures expressed in Australian Dollars (“A$”) have been converted from British Pounds Sterling at an exchange rate of AUD:GBP of 0.52, other than where noted. Doctor Care Anywhere Group PLC ARBN 645 163 873 13-15 Bouverie Street, 2nd Floor London EC4Y 8DP Commercial in confidence Summary FY 2024 Results FY24 FY23 Change % Underlying Revenue £m's 39.3 38.5 0.9 2.3% EBITDA £ms (0.5) (5.9) 5.4 91.3% Gross profit margin % 58.1% 46.0% 12.1ppt Contribution margin % 41.7% 28.1% 13.6ppt Detailed FY 2024 Consolidated Statement of Comprehensive Income £ in millions FY24 One-off FY24 underlying costs FY23 Variance % Revenue 39.3 39.3 38.5 0.9 2.3% (16.5) 22.9 58.1% (20.8) 17.7 46.0% 4.3 5.2 12.1ppt 20.7% 29.2% (6.5) 16.4 41.7% (6.9) 10.8 28.1% 0.4 5.6 13.6ppt 6.0% 51.7% 0.2 (0.8) (2.9) (13.3) 0.2 (0.1) (16.9) (0.7) (3.4) (12.9) 0.3 (0.1) (16.7) (0.1) 0.5 (0.4) (0.1) (0.1) (0.2) (13.1%) 13.5% (3.2%) (31.6%) (63.7%) (1.3%) Cost of sales Gross profit Gross profit margin (16.9) 22.4 57.0% Operating costs Contribution Contribution margin (6.5) 16.0 40.6% Sales and marketing Technology General and administration Other operating income Share based payment Non-operating costs (0.8) (2.9) (13.5) 0.2 (0.1) (17.1) EBITDA (1.1) 0.6 (0.5) (5.9) 5.4 91.3% Depreciation and amortisation Fair value adjustment EBIT (2.3) (1.2) (4.6) 1.2 1.8 (2.3) (2.8) (2.5) (8.4) 0.2 5.6 9.1% 66.7% Finance expense Loss before tax (0.7) (5.3) 0.7 2.5 (0.0) (2.8) (0.5) (8.9) 0.4 6.0 93.7% 68.1% Tax Loss after tax 0.1 (5.2) 2.5 0.1 (2.7) 0.7 (8.2) (0.6) 5.5 (80.5%) 67.1% Results from discontinued operations Net loss (1.2) (6.3) 1.0 3.4 (0.2) (2.9) (1.9) (10.0) 1.7 7.2 91.3% 71.6% 0.4 0.4 0.4 0.2 Please note numbers in the above table are subject to rounding differences. Revenue for FY24 reached £39.3 million, reflecting a 2.3% increase from FY23. Despite a reduction in consultation volumes, the primary driver of revenue growth was the annual price increase agreed with AXA in H1 24. We also benefitted from the timing of the agreement of certain specific additional revenue items. Excluding revenue from secondary care pathways, BAU revenue saw strong year-on-year growth as evidenced in the below table: Doctor Care Anywhere Group PLC ARBN 645 163 873 13-15 Bouverie Street, 2nd Floor London EC4Y 8DP Commercial in confidence BAU revenue Diagnostic revenue Total revenue £m's £m's £m's FY24 FY23 Change % 35.7 32.8 3.6 39.3 5.7 38.5 2.9 (2.0) 8.9% (35.9%) 0.9 2.3% Underlying gross profit has grown significantly, year on year: FY24 underlying gross profit was £22.9 million, up 29.2% on FY23. Underlying gross profit margin for FY24 was 58.1%, up 12.1ppt on FY23. Underlying contribution for FY24 was £16.4million, up 51.7% on FY23. contribution margin for FY24 was 41.7%, up 13.6ppt on FY23. Underlying Gross and contribution margin improvements were driven by three key factors: the growing use of ACPs in consultations (rising from 20% to 40% in FY24), a shift to more 15minute appointments, and higher revenue per consultation from annual price increases. Underlying non-operating costs in FY24 increased 1.3% on FY23, to £16.9 million. Excluding non-cash items, capitalisation and non-operating income, underlying non-operating costs fell by 2.4% over the same period from £19.1m to £18.6m. The company expects this to further reduce in 2025 following the initiation of the Company-wide transformation programme announced on 29 October 2024. Underlying EBITDA loss in FY24 was £0.5m, an improvement of £5.4m. This was driven by revenue growth, margin improvement and a focus on productivity in the business. DCA ended the year in a strong financial position with £4.4m in cash and its £10.6m convertible loan facility, with no repayments required until 31 December 2027. This liquidity provides a solid foundation to support the Company on its path to profitability and positive cash flow. 2024 Business Highlights 2024 was a year of progress for Doctor Care Anywhere, with several notable developments: • • • • £10.6m convertible loan note issue approved by shareholders in January 2024. Diversification of client base in year as new partnerships secured with Medichecks, Alliance Health and other clients won. Operating model efficiency improvements through a move to more 15-minute appointments and an increase in the percentage of ANP consultations. 40% by the end of 2024. Initiation of a wider transformation programme to drive further process efficiencies and cost reduction, enabling improved patient and client experience and to support DCA’s path to profitability. 2024 Guidance As per the 29 January 2025 market update, the Company hit all its 2024 market guidance following confirmation that underlying cash flow was broadly neutral in H2 2024. The Company was £0.2m cash generative from an underlying perspective. While actual cash burn in H2 2024 was £0.2m, there were non-underlying cashflows in the period of Doctor Care Anywhere Group PLC ARBN 645 163 873 13-15 Bouverie Street, 2nd Floor London EC4Y 8DP Commercial in confidence £0.4m consisting of one-off redundancy costs, legal costs and a temporary reduction in clinician utilisation related to the change in the clinical workforce mix initiated. 2025 Details regarding the Company’s strategic and financial plans for 2025 and beyond will be shared with this announcement through a management presentation. The Company is excited to share details of its opportunities to expand customer base and commercial propositions, and thus materially grow revenue and profitability. - ENDS This ASX announcement has been authorised for release by the Board of Directors. Forward looking statements: This announcement contains forward-looking statements which are statements that may be identified by words such as “may”, “will”, “would”, “should”, “could”, “believes”, “estimates”, “expects”, “intends”, “plans”, “anticipates”, “predicts”, “outlook”, “forecasts”, “guidance” and other similar words that involve risks and uncertainties. These statements are based on an assessment of present economic and operating conditions and on a number of best estimate assumptions regarding future events and actions that, at the date of this announcement, are expected to take place. Such forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties, assumptions and other important factors, many of which are beyond the control of the Company, and the directors and management of the Company. The Company cannot and does not give any assurance that the results, performance or achievements expressed or implied by the forward-looking statements contained in this announcement will actually occur and investors are cautioned not to place undue reliance on these forward-looking statements. About Doctor Care Anywhere: Doctor Care Anywhere Group PLC is one of the UK’s largest private providers of telehealth services. The Company works with insurers, healthcare providers and corporate customers to connect patients to a range of digitally enabled telehealth services on its proprietary platform. It is committed to delivering the best possible patient experience and clinical care through digitally enabled, joined up, evidence-based pathways. Further Information: Seema Sangar Chief Financial Officer Seema.sangar@doctorcareanywhere.com Doctor Care Anywhere Group PLC ARBN 645 163 873 13-15 Bouverie Street, 2nd Floor London EC4Y 8DP Commercial in confidence Appendix 4E - Preliminary Final Report FY2024 Doctor Care Anywhere Group PLC Year ended 31 December 2024 Reporting period Current reporting period (FY24): 1 January 2024 to 31 December 2024 Previous reporting period (FY23): 1 January 2023 to 31 December 2023 Basis of preparation This financial report has been prepared in accordance with measurement and recognition (but not disclosure) requirements of UK adopted international accounting standards in conformity with the requirements of the Companies Act 2006 (UK), in British Pounds Sterling. The non-statutory financial information in this report is based on the annual statutory financial statements which are in the process of being audited and have therefore not been finalised. Results for announcement to the market FY24 FY23 Variance to FY23 Variance % Revenue £m's 39.3 38.5 0.9 2.3% Net loss £m's (6.3) (10.0) 3.7 (37.3%) Net tangible loss per security £'s (0.02) (0.01) (0.01) 71.1% Revenue Revenue growth across the year was primarily driven by an increase in revenue earned per consultation. EBITDA to net loss reconciliation A summary of EBITDA reconciled back to net loss and then net underlying loss is as follows: Doctor Care Anywhere Group PLC ARBN 645 163 873 13-15 Bouverie Street, 2nd Floor London EC4Y 8DP Commercial in confidence FY24 FY23 Change % EBITDA to underlying EBITDA EBITDA Restructuring costs/clinician inefficiencies Underlying EBITDA £m's £m's £m's (1.1) 0.6 (0.5) (5.9) (5.9) 4.8 0.6 5.4 80.9% 91.3% Underlying EBITDA to net loss Interest Tax Depreciation and amortisation Restructuring costs/clinician inefficiencies Fair value adjustment Results from discontinued operations Net loss £m's £m's £m's £m's £m's £m's £m's (0.7) 0.1 (2.3) (0.6) (1.2) (1.2) (6.3) (0.5) 0.7 (2.5) (1.9) (10.0) (0.3) (0.6) 0.2 (0.6) (1.2) 0.7 3.7 (55.1%) 80.5% 9.1% 38.7% 37.3% Net loss to net underlying loss Fair value adjustment Restructuring costs/clinician inefficiencies Effective interest on convertible notes Impairment recorded in JV results GP2U Impairment charge Net underlying loss £m's £m's £m's £m's £m's £m's 1.2 0.6 0.7 1.0 (2.9) 1.7 (8.3) 1.2 0.6 1.0 (1.7) 5.5 100.0% 65.8% EBITDA loss in FY24 has substantially reduced to £1.1m, a decrease of 80.9% on FY23. This FY24 loss includes one off restructuring costs of £0.6m, therefore underlying EBITDA for FY24 is 0.5m. This EBITDA improvement is prominently driven by the improvements to gross profit and contribution. Net underlying loss for FY24 includes an adjustment of £1.2m to the fair value of the investment in My Emergency Doctor (MED). This is a non-cash item reflecting more challenging trading conditions in the Australian market. It also includes an adjustment for one-off restructuring costs of £0.6m representing redundancy, notice payments and professional consultancy costs for employees departing the organisation as we continue to drive meaningful productivity in the business to generate cash and profit. It also includes an adjustment for an effective interest charge of £0.7m occurring on the convertible notes as per IFRS requirements. Additionally, the Company’s results from discontinued operations include £1.0m related to an impairment in the Company’s joint venture Doctor at Hand Diagnostics. Adjusting for these items, net underlying loss for FY24 was £2.9m. Net loss for FY23 includes an impairment charge of £1.7m against the carrying value of GP2U. Excluding this charge, net underlying loss for FY23 was £8.3m. Taking into account these adjustments, net underlying loss for FY24 reduced by 65.8%, or £5.5m, compared with FY23. This is due to ongoing growth in the business and a focus on productivity improvements and margin expansion. Net tangible liabilities per security Net tangible liabilities increased by £2.8 million from £3.6 million at 31 December 2023 to £6.4 million at 31 December 2024 (up 75%). This was driven by the net loss of £6.3m in FY24 reduced by £3.1m related to the equity element of the issue of the convertible loan notes and movements in intangible assets in the period. As a result of the above, net tangible liabilities per security increased from £0.01 at 31 December 2023 to £0.02 at 31 December 2024 Doctor Care Anywhere Group PLC ARBN 645 163 873 13-15 Bouverie Street, 2nd Floor London EC4Y 8DP Commercial in confidence Dividends It is not proposed to pay any dividends, nor were any paid in the prior period. Joint ventures The Company is party to a joint venture with AXA Health, in respect of Doctor at Hand Diagnostics Limited. As announced on 18 October 2023, it is the joint venture parties’ intention to wind up this entity, with completion expected in H1 2025. The intellectual property owned by the JV (consisting principally of the technology that enables diagnostic referral pathway management) will be transferred to DCA on winding up. Doctor Care Anywhere Group PLC ARBN 645 163 873 13-15 Bouverie Street, 2nd Floor London EC4Y 8DP Commercial in confidence Financial Statements Consolidated Statement of Comprehensive Income Note Revenue Cost of sales Gross profit Administrative expenses Other operating income Operating loss Finance income Finance expense Loss before taxation Tax credit Loss for the financial year from continuing operations Loss on discontinued operations net of tax Total comprehensive loss for the year Unaudited Year ended 31 December 2024 £000’s Audited Year ended 31 December 2023 £000’s 39,333 (16,913) 22,420 (27,226) 246 (4,560) 115 (828) (5,273) 135 38,462 (20,769) 17,693 (26,429) 334 (8,402) 48 (507) (8,861) 695 (5,138) (8,166) (1,153) (1,883) (6,291) (10,049) £ (0.02) £ (0.03) (0.01) (0.02) 1 2 4 3 Loss per share: Basic and diluted loss per share attributable to ordinary equity shareholders Basic and diluted loss per share attributable to ordinary equity shareholders – continuing operations Doctor Care Anywhere Group PLC ARBN 645 163 873 13-15 Bouverie Street, 2nd Floor London EC4Y 8DP Commercial in confidence Consolidated Statement of Financial Position Note Non-current assets Property, plant and equipment Intangible assets Investments Total non-current assets Current assets Trade and other receivables: due within one year Corporation tax receivable Cash and cash equivalents Interest in joint venture Total current assets Current liabilities Trade and other payables: due within one year Loans and borrowings Unaudited 31 December 2024 £’000 Audited 31 December 2023 £’000 5 6 254 5,828 140 6,222 747 5,968 1,300 8,015 7 2,960 3,110 523 4,407 881 8,771 387 6,061 2,034 11,592 8 (6,824) (5,918) 10 - (3,846) (6,824) (9,764) 9 (750) (956) 10 (8,064) (6,555) (8,814) (7,511) (645) 2,332 78 56,212 5,485 (62,420) (645) 78 56,212 2,171 (56,129) 2,332 Total current liabilities Non-current liabilities Trade and other payables: due after one year Loans and borrowings Total non-current liabilities Net (liabilities)/assets Capital and reserves Called up share capital Share premium account Other reserves Retained losses Total equity 11 Doctor Care Anywhere Group PLC ARBN 645 163 873 13-15 Bouverie Street, 2nd Floor London EC4Y 8DP Commercial in confidence Consolidated Statement of Changes in Equity Notes Called up share capital Share premium account Other reserves £’000 £’000 £’000 £’000 £’000 £’000 £’000 £’000 £’000 £’000 78 56,212 2,078 (46,080) 12,288 Comprehensive loss for the year - - - (10,049) (10,049) Total comprehensive loss for the year - - - (10,049) (10,049) Shares Issued - - - - - Total shares issued during the year - - - - - Share based payments - - 81 - 81 Foreign exchange movements - - 12 - 12 At 31 December 2023 (audited) 78 56,212 2,171 (56,129) 2,332 Comprehensive loss for the year - - - (6,291) (6,291) Total comprehensive loss for the year - - - (6,291) (6,291) Shares Issued - - - - - Total shares issued during the year - - - - - Share based payments - - 161 - 161 Issue of convertible loan notes - - 3,132 - 3,132 Foreign exchange movements - - 21 - 21 78 56,212 5,485 (62,420) (645) At 1 January 2023 At 31 December 2024 (unaudited) Doctor Care Anywhere Group PLC ARBN 645 163 873 13-15 Bouverie Street, 2nd Floor London EC4Y 8DP Retained Total equity losses Commercial in confidence Consolidated Statement of Cash Flows Unaudited Year ended 31 December 2024 £’000 Audited Year ended 31 December 2023 £’000 40,441 (40,150) 62 - 38,863 (45,951) (1) 48 700 Total cash flows from Operating Activities 353 (6,341) Cash flows from Investing Activities Payment for property, plant and equipment (6) (167) Payment for intangible fixed assets Proceeds from disposals of entities (1,645) - (2,160) 90 Total cash flows from Investing Activities (1,651) (2,237) (103) - 10,610 (10,839) 10,000 (684) (332) 9,316 Net cash (outflows)/inflows (1,630) 738 Cash and cash equivalents at beginning of year Effect of movement in exchange rates on cash held Cash and cash equivalents at the end of year 6,061 5,406 (24) (83) 4,407 6,061 Cash flows from Operating Activities Receipts from customers Payments to suppliers and employees Finance cost paid Finance cost received Government grants and tax incentives Cash flows from Financing Activities Transaction costs related to issues of convertible debt securities Proceeds from borrowings Repayment of loans Total cash flows from Financing Activities Doctor Care Anywhere Group PLC ARBN 645 163 873 13-15 Bouverie Street, 2nd Floor London EC4Y 8DP Commercial in confidence Note 1: Revenue Year ended 31 December 2024 £000’s Year ended 31 December 2023 £000’s 37,344 1,984 5 39,333 35,998 2,459 5 38,462 Year ended 31 December 2024 £000’s Year ended 31 December 2023 £000’s 6,464 2,907 801 17,054 27,226 6,878 3,361 709 15,481 26,429 Utilisation Subscription Other Total Note 2: Administrative Expenses Operating costs Technology costs Sales and marketing costs General and administration costs Total Operations includes the expenses attributable to the delivery of the Group’s core services. Technology costs include the expenses attributable to the development and maintenance of the Group’s intellectual property. Sales and marketing costs include the expenses attributable to the selling and marketing of the Group’s services. General and administration costs include the expenses attributable to supporting the Group’s operating functions, depreciation (FY24: £0.5m, FY23: £0.6m), amortisation (FY24: £1.m, FY23: £1.8m) and share-based payments (FY24: £0.1m, FY23: £0.1m). Doctor Care Anywhere Group PLC ARBN 645 163 873 13-15 Bouverie Street, 2nd Floor London EC4Y 8DP Commercial in confidence Note 3: Discontinued operations On 4 June 2023, the Company announced the sale of its Australian subsidiary GP2U for A$3.0m to My Emergency Doctor. The consideration comprised of $2.5m unlisted ordinary shares in MED and $0.5m cash adjusted for normal working capital. The sale was completed on 9 July 2023, and consequently GP2U’s operations have been classified as discontinued for the year ended 31 December 2023. On 18 October 2023, as part of its quarterly activity report, the Company gave an update regarding its relationship with AXA Health. As part of this update, the Company announced the intention to wind up its Joint Venture Doctor at Hand Diagnostics ("JVCo"). This remains the intention at the date of this report, and consequently JVCo has been classified as discontinued for both years. The result from discontinued operations in the year was determined as follows: Loss attributable to GP2U Gain on disposal Share of (loss)/profit of joint venture Total Year ended 31 December 2024 Note £000’s 3a 3b (1,153) (1,153) Year ended 31 December 2023 £000’s (1,965) 14 68 (1,883) Year ended 31 December 2024 £000’s - Year ended 31 December 2023 £000’s 360 (619) 27 (1,733) (1,965) 3a – Loss attributable to GP2U Revenue Administrative expenses Tax Intangible asset impairment Total The 2024 loss for the year includes a £1.0m intangible impairment which was recorded in the joint venture. The 2023 Intangible asset impairment relates to an impairment of GP2U intangible assets to bring the net assets of GP2U in line with the recoverable value. Doctor Care Anywhere Group PLC ARBN 645 163 873 13-15 Bouverie Street, 2nd Floor London EC4Y 8DP Commercial in confidence 3b – Profit on disposal of GP2U Year ended 31 December 2023 £000’s 1,471 (1,457) 14 Consideration received less costs to sell Net assets of GP2U at date of disposal Profit on disposal Note 4: Finance Expense Interest expense on financial liabilities held at amortised cost Total Year ended 31 December 2024 £000’s 828 Year ended 31 December 2023 £000’s 507 828 507 Total Note 5: Property, plant and equipment Right of use asset £000’s Office equipment £000’s Computer equipment £000’s £000’s Cost At 1 January 2024 Additions Disposals At 31 December 2024 1,321 1,321 233 1 (118) 116 740 6 (519) 227 2,294 7 (637) 1,664 Depreciation At 1 January 2024 Charge for the period Disposals At 31 December 2024 870 292 1,162 159 54 (118) 95 518 154 (519) 153 1,547 500 (637) 1,410 Net book value At 31 December 2024 At 31 December 2023 159 451 21 74 74 222 254 747 Doctor Care Anywhere Group PLC ARBN 645 163 873 13-15 Bouverie Street, 2nd Floor London EC4Y 8DP Commercial in confidence Note 6: Intangible assets Cost At 1 January 2024 Additions Disposals At 31 December 2024 Amortisation At 1 January 2024 Charge for the year Disposals Impairment At 31 December 2024 Net book value At 31 December 2024 At 31 December 2023 Trade names Customer relationships Patents Technical know-how Software onboarding costs £000’s Software development costs £000’s £000’s £000’s £000’s £000’s 75 - 1,424 - 50 - 500 - 75 1,424 50 75 - 1,424 - 75 £000’s 500 124 3 (71) 56 10,852 1,645 12,497 13,025 1,648 (71) 14,602 50 - 500 - 112 10 (71) - 4,895 1,705 74 7,057 1,715 (71) 74 1,424 50 500 51 6,674 8,774 - - - - 5 5,823 5,828 - - - - 11 5,957 5,968 Doctor Care Anywhere Group PLC ARBN 645 163 873 13-15 Bouverie Street, 2nd Floor London EC4Y 8DP Total Commercial in confidence Note 7: Trade and other receivables (due within one year) As at 31 December 2024 £000’s As at 31 December 2023 £000’s 1,336 91 1,153 380 2,960 1,904 218 950 38 3,110 Held at amortised cost Trade receivables Other receivables Prepayments Contract assets Total The group has no trade or other receivable balances due after more than one year. Note 8: Trade and other payables (due within one year) As at 31 December 2024 £000’s As at 31 December 2023 £000’s 206 2,461 584 265 2,619 689 6,824 392 1,858 755 38 2,261 614 5,918 As at 31 December 2024 £000’s As at 31 December 2023 £000’s 750 750 207 749 956 Held at amortised cost IFRS 16 lease liability Trade payables Other taxation and social security Other payables Accruals Contract liabilities Total Note 9: Trade and other payables (due after one year) Held at amortised cost IFRS 16 lease liability Other payables Total Doctor Care Anywhere Group PLC ARBN 645 163 873 13-15 Bouverie Street, 2nd Floor London EC4Y 8DP Commercial in confidence Note 10: Loans and borrowings As at 31 December 2024 £000’s As at 31 December 2023 £000’s Amounts falling due within one year Non-Current liabilities - 3,846 Amounts falling due after one year 8,064 6,555 Current liabilities The current year non-current liabilities relate to convertible loan notes issued on 11 January 2024. The key terms of the note are as follows: • Convertible Notes have no coupon interest and are due 31 December 2027, with no repayment of principal required until maturity • Conversion price of £0.04591 (A$0.0875), a premium of 94% to the closing price on 11 December 2023, the last trading date of the CDIs prior to the announcement of the transactions • A Noteholder has the right to convert all or some of their notes upon issuance of conversion notice • Initial £10.6m loan note split £7.7m to liability, £3.1m to equity with remaining £0.167m of costs being unwound evenly to liability over the term of the notes • Fair value of the liability was determined using an unsecured market rate of interest of 9.15% and discounted over the term of the loan • Effective interest of £683,332 of effective interest has been recorded in the year using the unsecured market rate of interest of 9.15% • Zero coupon and no interim repayments • Funds used to repay the AXA Loan and accrued interest of £0.4m AXA Health and Axia Investments Limited participated in the Convertible Notes Doctor Care Anywhere Group PLC ARBN 645 163 873 13-15 Bouverie Street, 2nd Floor London EC4Y 8DP Commercial in confidence Note 11: Share capital As at 31 December 2024 At as 31 December 2023 Shares on issue Ordinary Deferred ordinary Total shares in issue 366,672,246 99,600 366,771,846 366,672,246 99,600 366,771,846 Nominal value Ordinary Deferred ordinary £0.000167 £0.167 £0.000167 £0.167 Share capital Ordinary Deferred ordinary Total share capital £000’s 61 17 78 £000’s 61 17 78 Deferred shares carry no voting or economic rights other than the return of the issue price. All other classes of shares entitle the holder to receive notice of and to attend, speak and to vote at any general meeting. No classes of shares confer rights of redemption. Securities in the Company traded on the ASX are in the form of Chess Depository Interests (CDIs). CDIs are a type of depositary receipt that allows investors to obtain all the economic benefits of share ownership without holding legal title to the shares themselves. A CDI represents the beneficial interest in underlying shares in a Company. Shares underlying the CDIs are held by an Australian depositary nominee as the legal owner on behalf and for the benefit of the CDI holder. The holders of CDIs receive all the economic benefit of actual ownership of the underlying shares. Note 12: Events after the reporting date There were no events after the reporting date Doctor Care Anywhere Group PLC ARBN 645 163 873 13-15 Bouverie Street, 2nd Floor London EC4Y 8DP